State Of Wyoming Tg Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $1,741 - $4,560	-223 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $836 - $1,953	-55 Reduced 19.78%	223 $4,000
Q3 2021 Feb 11, 2022	SELL	$21.78 - $40.45 $4,377 - $8,130	-201 Reduced 41.96%	278 $9,000
Q2 2021 Feb 11, 2022	BUY	$32.5 - $48.96 $9,197 - $13,855	283 Added 144.39%	479 $19,000
Q1 2021 Feb 08, 2022	BUY	$41.61 - $54.3 $8,155 - $10,642	196 New	196 $9,000

287

91.8M

1.9M

1.45M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.